[{"id":"7c89998c-ad05-46fc-b5b5-f616ad2f3924","acronym":"","url":"https://clinicaltrials.gov/study/NCT01614990","created_at":"2021-01-18T06:55:08.185Z","updated_at":"2024-07-02T16:35:13.819Z","phase":"Phase 2","brief_title":"Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia","source_id_and_acronym":"NCT01614990","lead_sponsor":"Garcia, Jose M., MD, PhD","biomarkers":" IL6 • IGF1 • IGFBP3","pipe":"","alterations":" ","tags":["IL6 • IGF1 • IGFBP3"],"overall_status":"Completed","enrollment":" Enrollment 15","initiation":"Initiation: 05/01/2012","start_date":" 05/01/2012","primary_txt":" Primary completion: 07/01/2020","primary_completion_date":" 07/01/2020","study_txt":" Completion: 12/01/2021","study_completion_date":" 12/01/2021","last_update_posted":"2024-03-20"},{"id":"4fb5c92f-18b4-4d65-bf79-c66ecdb1415b","acronym":"","url":"https://clinicaltrials.gov/study/NCT02103140","created_at":"2021-01-18T09:43:04.208Z","updated_at":"2024-07-02T16:35:18.978Z","phase":"","brief_title":"An Exercise RCT Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancer","source_id_and_acronym":"NCT02103140","lead_sponsor":"Georgetown University","biomarkers":" IL6 • TNFA • IGFBP3","pipe":"","alterations":" ","tags":["IL6 • TNFA • IGFBP3"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 213","initiation":"Initiation: 01/01/2012","start_date":" 01/01/2012","primary_txt":" Primary completion: 09/01/2023","primary_completion_date":" 09/01/2023","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-02-19"},{"id":"c59318de-d8cc-4b40-8c58-fe8ed2c52d35","acronym":"","url":"https://clinicaltrials.gov/study/NCT04722341","created_at":"2021-01-25T15:53:22.768Z","updated_at":"2024-07-02T16:35:29.681Z","phase":"","brief_title":"Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators","source_id_and_acronym":"NCT04722341","lead_sponsor":"Cedars-Sinai Medical Center","biomarkers":" IGFBP3","pipe":"","alterations":" ","tags":["IGFBP3"],"overall_status":"Recruiting","enrollment":" Enrollment 300","initiation":"Initiation: 01/01/2022","start_date":" 01/01/2022","primary_txt":" Primary completion: 06/30/2026","primary_completion_date":" 06/30/2026","study_txt":" Completion: 12/31/2026","study_completion_date":" 12/31/2026","last_update_posted":"2023-11-09"},{"id":"33e40c58-3af8-42e4-bc3b-c3a150fef3e3","acronym":"","url":"https://clinicaltrials.gov/study/NCT05217147","created_at":"2022-02-05T18:28:09.104Z","updated_at":"2024-07-02T16:35:35.953Z","phase":"","brief_title":"An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma","source_id_and_acronym":"NCT05217147","lead_sponsor":"Hacettepe University","biomarkers":" ENG • IGFBP3","pipe":"","alterations":" ","tags":["ENG • IGFBP3"],"overall_status":"Completed","enrollment":" Enrollment 80","initiation":"Initiation: 05/01/2018","start_date":" 05/01/2018","primary_txt":" Primary completion: 02/01/2020","primary_completion_date":" 02/01/2020","study_txt":" Completion: 08/31/2021","study_completion_date":" 08/31/2021","last_update_posted":"2023-09-22"},{"id":"a843ae44-5321-4abe-966d-15fdb296c3be","acronym":"","url":"https://clinicaltrials.gov/study/NCT02990130","created_at":"2021-07-30T23:54:19.109Z","updated_at":"2024-07-02T16:35:36.886Z","phase":"","brief_title":"Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation","source_id_and_acronym":"NCT02990130","lead_sponsor":"Garcia, Jose M., MD, PhD","biomarkers":" IL6 • TNFA • IGFBP3","pipe":"","alterations":" ","tags":["IL6 • TNFA • IGFBP3"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 11/01/2016","start_date":" 11/01/2016","primary_txt":" Primary completion: 12/01/2022","primary_completion_date":" 12/01/2022","study_txt":" Completion: 07/01/2024","study_completion_date":" 07/01/2024","last_update_posted":"2023-09-15"},{"id":"630319d6-7476-4345-9ba2-bdb41e52946d","acronym":"BWEL","url":"https://clinicaltrials.gov/study/NCT02750826","created_at":"2021-01-18T13:28:41.714Z","updated_at":"2024-07-02T16:35:38.388Z","phase":"Phase 3","brief_title":"Breast Cancer WEight Loss Study (BWEL Study)","source_id_and_acronym":"NCT02750826 - BWEL","lead_sponsor":"Alliance for Clinical Trials in Oncology","biomarkers":" HER-2 • ER • PGR • IL6 • TNFA • IGF1 • IGFBP3 • LEP","pipe":" | ","alterations":" HER-2 positive • HR positive • PGR positive","tags":["HER-2 • ER • PGR • IL6 • TNFA • IGF1 • IGFBP3 • LEP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • HR positive • PGR positive"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 3177","initiation":"Initiation: 08/01/2016","start_date":" 08/01/2016","primary_txt":" Primary completion: 05/01/2030","primary_completion_date":" 05/01/2030","study_txt":"","study_completion_date":"","last_update_posted":"2023-08-31"},{"id":"eef0bcb7-c9b6-43f9-a518-a4a82f147441","acronym":"TAM-01","url":"https://clinicaltrials.gov/study/NCT01357772","created_at":"2021-01-18T05:33:13.038Z","updated_at":"2024-07-02T16:35:42.792Z","phase":"Phase 3","brief_title":"Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up","source_id_and_acronym":"NCT01357772 - TAM-01","lead_sponsor":"Andrea DeCensi","biomarkers":" ER • IGFBP3","pipe":" | ","alterations":" ER positive","tags":["ER • IGFBP3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e tamoxifen"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 500","initiation":"Initiation: 11/12/2008","start_date":" 11/12/2008","primary_txt":" Primary completion: 12/31/2022","primary_completion_date":" 12/31/2022","study_txt":" Completion: 12/31/2028","study_completion_date":" 12/31/2028","last_update_posted":"2023-07-17"},{"id":"bb9997f0-453a-4083-9fab-d8017d881de5","acronym":"1R01CA172444-01A1","url":"https://clinicaltrials.gov/study/NCT02028221","created_at":"2021-01-18T09:17:16.755Z","updated_at":"2024-07-02T16:35:44.648Z","phase":"Phase 2","brief_title":"Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk","source_id_and_acronym":"NCT02028221 - 1R01CA172444-01A1","lead_sponsor":"University of Arizona","biomarkers":" IGF1 • IGF2 • IGFBP3 • LEP","pipe":"","alterations":" ","tags":["IGF1 • IGF2 • IGFBP3 • LEP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e metformin"],"overall_status":"Completed","enrollment":" Enrollment 151","initiation":"Initiation: 03/07/2014","start_date":" 03/07/2014","primary_txt":" Primary completion: 11/30/2018","primary_completion_date":" 11/30/2018","study_txt":" Completion: 06/14/2022","study_completion_date":" 06/14/2022","last_update_posted":"2023-06-27"},{"id":"8a3b861b-e6d7-4999-9657-66fbacd7d7d6","acronym":"TEXT-Bone","url":"https://clinicaltrials.gov/study/NCT00963417","created_at":"2021-01-18T03:45:06.718Z","updated_at":"2024-07-02T16:35:46.911Z","phase":"","brief_title":"Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02","source_id_and_acronym":"NCT00963417 - TEXT-Bone","lead_sponsor":"ETOP IBCSG Partners Foundation","biomarkers":" IGF1 • IGFBP3","pipe":" | ","alterations":" HR positive","tags":["IGF1 • IGFBP3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HR positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e tamoxifen • exemestane • triptorelin"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 119","initiation":"Initiation: 08/03/2009","start_date":" 08/03/2009","primary_txt":" Primary completion: 03/11/2011","primary_completion_date":" 03/11/2011","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2023-05-31"},{"id":"81495bd9-2ae2-4b7a-bf03-c5d38eafb6ae","acronym":"","url":"https://clinicaltrials.gov/study/NCT04266353","created_at":"2021-01-18T20:43:49.572Z","updated_at":"2024-07-02T16:35:48.613Z","phase":"","brief_title":"Effect of Resveratrol on Serum IGF2 Among African American Women","source_id_and_acronym":"NCT04266353","lead_sponsor":"Loma Linda University","biomarkers":" IGF2 • IGFBP3","pipe":"","alterations":" ","tags":["IGF2 • IGFBP3"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 04/24/2019","start_date":" 04/24/2019","primary_txt":" Primary completion: 08/22/2022","primary_completion_date":" 08/22/2022","study_txt":" Completion: 08/22/2022","study_completion_date":" 08/22/2022","last_update_posted":"2023-05-09"},{"id":"86e49f68-a178-4f4c-ac68-cc150770c1f8","acronym":"","url":"https://clinicaltrials.gov/study/NCT05850559","created_at":"2023-05-09T14:04:30.021Z","updated_at":"2024-07-02T16:35:48.661Z","phase":"","brief_title":"Assessment of the Diagnostic Role of Serum Insulin-like Growth Factor Binding Protein-3 as a Potential Biomarker for Colorectal Cancer (CRC) in Egypt","source_id_and_acronym":"NCT05850559","lead_sponsor":"Assiut University","biomarkers":" IGFBP3","pipe":"","alterations":" ","tags":["IGFBP3"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 10/05/2023","start_date":" 10/05/2023","primary_txt":" Primary completion: 10/01/2025","primary_completion_date":" 10/01/2025","study_txt":" Completion: 10/01/2026","study_completion_date":" 10/01/2026","last_update_posted":"2023-05-09"},{"id":"0a35d3c0-57af-4e09-9c05-bc2f2fae9bf5","acronym":"LungMaas","url":"https://clinicaltrials.gov/study/NCT05794529","created_at":"2023-04-03T15:03:26.250Z","updated_at":"2024-07-02T16:35:51.641Z","phase":"","brief_title":"Lung Tumor Protein Synthesis Rates in Lung Cancer Patients","source_id_and_acronym":"NCT05794529 - LungMaas","lead_sponsor":"Maastricht University Medical Center","biomarkers":" IL6 • TNFA • IGF1 • IL10 • IGFBP3 • IGFBP1","pipe":"","alterations":" ","tags":["IL6 • TNFA • IGF1 • IL10 • IGFBP3 • IGFBP1"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 03/01/2023","start_date":" 03/01/2023","primary_txt":" Primary completion: 03/01/2026","primary_completion_date":" 03/01/2026","study_txt":" Completion: 03/01/2026","study_completion_date":" 03/01/2026","last_update_posted":"2023-04-03"},{"id":"4440793a-ab83-4b82-b144-f3e5b46b6fe3","acronym":"","url":"https://clinicaltrials.gov/study/NCT05748704","created_at":"2023-03-01T15:01:57.757Z","updated_at":"2024-07-02T16:35:54.508Z","phase":"Phase 1","brief_title":"Metabolic and Immunological Effects of a Modified Fasting Regimen in Cancer Patients","source_id_and_acronym":"NCT05748704","lead_sponsor":"University of Genova","biomarkers":" CD8 • IL6 • TNFA • IL2RA • PTPRC • IGF1 • NCAM1 • ENTPD1 • IGFBP3 • IL1B • IGFBP1 • ISG20 • LEP","pipe":"","alterations":" ","tags":["CD8 • IL6 • TNFA • IL2RA • PTPRC • IGF1 • NCAM1 • ENTPD1 • IGFBP3 • IL1B • IGFBP1 • ISG20 • LEP"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 11/01/2021","start_date":" 11/01/2021","primary_txt":" Primary completion: 11/01/2025","primary_completion_date":" 11/01/2025","study_txt":" Completion: 11/01/2025","study_completion_date":" 11/01/2025","last_update_posted":"2023-03-01"},{"id":"da45ec2c-9188-417f-b7ba-8299cf3d83fd","acronym":"LETSGO","url":"https://clinicaltrials.gov/study/NCT04122235","created_at":"2021-01-18T20:08:48.072Z","updated_at":"2024-07-02T16:35:57.062Z","phase":"","brief_title":"The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study","source_id_and_acronym":"NCT04122235 - LETSGO","lead_sponsor":"Sorlandet Hospital HF","biomarkers":" TNFA • IL10 • IGFBP3","pipe":"","alterations":" ","tags":["TNFA • IL10 • IGFBP3"],"overall_status":"Recruiting","enrollment":" Enrollment 754","initiation":"Initiation: 11/18/2019","start_date":" 11/18/2019","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 12/31/2030","study_completion_date":" 12/31/2030","last_update_posted":"2023-01-26"},{"id":"add0ee50-c350-48db-bccf-2fe3e7c0a381","acronym":"OFCS","url":"https://clinicaltrials.gov/study/NCT05623852","created_at":"2022-11-21T14:57:12.371Z","updated_at":"2024-07-02T16:36:00.125Z","phase":"Phase 2","brief_title":"The Impact of Oligo-Fucoidan in Cancer Cachexia and Sarcopenia","source_id_and_acronym":"NCT05623852 - OFCS","lead_sponsor":"Taipei Medical University WanFang Hospital","biomarkers":" IL6 • TNFA • IGF1 • IGFBP3","pipe":"","alterations":" ","tags":["IL6 • TNFA • IGF1 • IGFBP3"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 01/30/2022","start_date":" 01/30/2022","primary_txt":" Primary completion: 04/30/2024","primary_completion_date":" 04/30/2024","study_txt":" Completion: 04/30/2025","study_completion_date":" 04/30/2025","last_update_posted":"2022-11-21"},{"id":"0a96174c-2273-4bb4-8270-7fc5385f450f","acronym":"ESIBAC","url":"https://clinicaltrials.gov/study/NCT05531695","created_at":"2022-09-08T14:56:12.669Z","updated_at":"2024-07-02T16:36:04.270Z","phase":"","brief_title":"Exercise Study in Brain and CNS Cancer","source_id_and_acronym":"NCT05531695 - ESIBAC","lead_sponsor":"Hull University Teaching Hospitals NHS Trust","biomarkers":" IL6 • IGF1 • IGFBP3 • CRP","pipe":"","alterations":" ","tags":["IL6 • IGF1 • IGFBP3 • CRP"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 11/01/2016","start_date":" 11/01/2016","primary_txt":" Primary completion: 07/01/2018","primary_completion_date":" 07/01/2018","study_txt":" Completion: 08/01/2018","study_completion_date":" 08/01/2018","last_update_posted":"2022-09-08"},{"id":"e2ba8f73-021f-4815-bd4f-48ebd4e397b8","acronym":"","url":"https://clinicaltrials.gov/study/NCT02278965","created_at":"2021-01-18T10:43:45.075Z","updated_at":"2024-07-02T16:36:05.372Z","phase":"Phase 1","brief_title":"Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer","source_id_and_acronym":"NCT02278965","lead_sponsor":"Katherine D. Crew","biomarkers":" IL6 • IGF1 • IGFBP3 • CRP • IGFBP1 • LEP","pipe":"","alterations":" ","tags":["IL6 • IGF1 • IGFBP3 • CRP • IGFBP1 • LEP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e metformin"],"overall_status":"Completed","enrollment":" Enrollment 19","initiation":"Initiation: 01/22/2015","start_date":" 01/22/2015","primary_txt":" Primary completion: 04/19/2017","primary_completion_date":" 04/19/2017","study_txt":" Completion: 04/19/2017","study_completion_date":" 04/19/2017","last_update_posted":"2022-08-17"},{"id":"a932dede-bcd1-4656-9cba-c478bcbe6995","acronym":"","url":"https://clinicaltrials.gov/study/NCT03045289","created_at":"2021-01-18T14:59:55.632Z","updated_at":"2024-07-02T16:36:07.343Z","phase":"","brief_title":"A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer","source_id_and_acronym":"NCT03045289","lead_sponsor":"University of Rochester","biomarkers":" HER-2 • PGR • IGFBP3","pipe":"","alterations":" ","tags":["HER-2 • PGR • IGFBP3"],"overall_status":"Completed","enrollment":" Enrollment 32","initiation":"Initiation: 07/05/2018","start_date":" 07/05/2018","primary_txt":" Primary completion: 07/01/2022","primary_completion_date":" 07/01/2022","study_txt":" Completion: 07/01/2022","study_completion_date":" 07/01/2022","last_update_posted":"2022-07-13"},{"id":"315e894b-0d1b-4d38-8c6b-e53b589b4266","acronym":"","url":"https://clinicaltrials.gov/study/NCT01156545","created_at":"2022-04-07T06:53:13.464Z","updated_at":"2024-07-02T16:36:13.884Z","phase":"Phase 2","brief_title":"BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC","source_id_and_acronym":"NCT01156545","lead_sponsor":"National Cancer Center, Korea","biomarkers":" IGFBP3","pipe":" | ","alterations":" EGFR mutation","tags":["IGFBP3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Gilotrif (afatinib) • simvastatin"],"overall_status":"Completed","enrollment":" Enrollment 68","initiation":"Initiation: 10/01/2010","start_date":" 10/01/2010","primary_txt":" Primary completion: 12/31/2016","primary_completion_date":" 12/31/2016","study_txt":" Completion: 06/09/2021","study_completion_date":" 06/09/2021","last_update_posted":"2022-04-06"},{"id":"ed947a4e-26aa-4ea8-86fd-a0a540d0ffe5","acronym":"","url":"https://clinicaltrials.gov/study/NCT05248282","created_at":"2022-02-21T13:52:37.680Z","updated_at":"2024-07-02T16:36:16.846Z","phase":"","brief_title":"Clinical Validation of the Prognostic Value of the PrTS on Prostate Cancer Patients","source_id_and_acronym":"NCT05248282","lead_sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","biomarkers":" IGFBP3","pipe":"","alterations":" ","tags":["IGFBP3"],"overall_status":"Recruiting","enrollment":" Enrollment 150","initiation":"Initiation: 09/01/2021","start_date":" 09/01/2021","primary_txt":" Primary completion: 04/30/2022","primary_completion_date":" 04/30/2022","study_txt":" Completion: 12/31/2022","study_completion_date":" 12/31/2022","last_update_posted":"2022-02-21"},{"id":"a76d8864-1f41-44b1-8ede-55554d3c0b78","acronym":"SPIRIT","url":"https://clinicaltrials.gov/study/NCT02431676","created_at":"2021-01-18T11:38:12.371Z","updated_at":"2024-07-02T16:36:40.940Z","phase":"Phase 2","brief_title":"Survivorship Promotion In Reducing IGF-1 Trial","source_id_and_acronym":"NCT02431676 - SPIRIT","lead_sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","biomarkers":" IGF1 • IGFBP3","pipe":"","alterations":" ","tags":["IGF1 • IGFBP3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e metformin"],"overall_status":"Completed","enrollment":" Enrollment 121","initiation":"Initiation: 05/01/2015","start_date":" 05/01/2015","primary_txt":" Primary completion: 12/01/2018","primary_completion_date":" 12/01/2018","study_txt":" Completion: 12/01/2018","study_completion_date":" 12/01/2018","last_update_posted":"2020-09-16"},{"id":"fd715347-6526-4812-b1ae-4f26e4a774e6","acronym":"","url":"https://clinicaltrials.gov/study/NCT02152462","created_at":"2021-01-18T10:00:22.443Z","updated_at":"2024-07-02T16:36:50.231Z","phase":"Phase 2","brief_title":"Exergaming Intervention and Breast Cancer Biomarkers in Black Women","source_id_and_acronym":"NCT02152462","lead_sponsor":"Georgetown University","biomarkers":" IL6 • IGF1 • IGFBP3 • CRP • LEP","pipe":"","alterations":" ","tags":["IL6 • IGF1 • IGFBP3 • CRP • LEP"],"overall_status":"Completed","enrollment":" Enrollment 150","initiation":"Initiation: 12/01/2012","start_date":" 12/01/2012","primary_txt":" Primary completion: 09/01/2014","primary_completion_date":" 09/01/2014","study_txt":" Completion: 12/01/2019","study_completion_date":" 12/01/2019","last_update_posted":"2020-02-10"},{"id":"88188f35-d70b-4646-8e6f-f73378f6900c","acronym":"","url":"https://clinicaltrials.gov/study/NCT02095145","created_at":"2021-01-18T09:40:12.649Z","updated_at":"2024-07-02T16:36:50.588Z","phase":"Phase 2a","brief_title":"Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance","source_id_and_acronym":"NCT02095145","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" IGF1 • CASP3 • IGFBP3","pipe":"","alterations":" ","tags":["IGF1 • CASP3 • IGFBP3"],"overall_status":"Completed","enrollment":" Enrollment 38","initiation":"Initiation: 05/08/2014","start_date":" 05/08/2014","primary_txt":" Primary completion: 01/23/2018","primary_completion_date":" 01/23/2018","study_txt":" Completion: 09/26/2019","study_completion_date":" 09/26/2019","last_update_posted":"2020-02-05"},{"id":"cc48369b-6182-4455-8640-ddddcf979296","acronym":"","url":"https://clinicaltrials.gov/study/NCT00450749","created_at":"2021-01-18T01:35:44.785Z","updated_at":"2024-07-02T16:36:52.255Z","phase":"Phase 2","brief_title":"Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer","source_id_and_acronym":"NCT00450749","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" GSTP1 • IGFBP3 • KLK2","pipe":"","alterations":" ","tags":["GSTP1 • IGFBP3 • KLK2"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 02/01/2008","start_date":" 02/01/2008","primary_txt":" Primary completion: 05/01/2010","primary_completion_date":" 05/01/2010","study_txt":" Completion: 05/01/2010","study_completion_date":" 05/01/2010","last_update_posted":"2019-12-18"}]